Cargando…
A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812696/ https://www.ncbi.nlm.nih.gov/pubmed/34855641 http://dx.doi.org/10.1097/CM9.0000000000001614 |
| _version_ | 1784644709670453248 |
|---|---|
| author | Zhang, Fengqin Wei, Yanqiu He, Li Zhang, Huilan Hu, Qiongjie Yue, Huihui He, Jianhan Dai, Huaping |
| author_facet | Zhang, Fengqin Wei, Yanqiu He, Li Zhang, Huilan Hu, Qiongjie Yue, Huihui He, Jianhan Dai, Huaping |
| author_sort | Zhang, Fengqin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8812696 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88126962022-02-04 A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 Zhang, Fengqin Wei, Yanqiu He, Li Zhang, Huilan Hu, Qiongjie Yue, Huihui He, Jianhan Dai, Huaping Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2022-02-05 2021-12-01 /pmc/articles/PMC8812696/ /pubmed/34855641 http://dx.doi.org/10.1097/CM9.0000000000001614 Text en Copyright © 2021 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
| spellingShingle | Correspondence Zhang, Fengqin Wei, Yanqiu He, Li Zhang, Huilan Hu, Qiongjie Yue, Huihui He, Jianhan Dai, Huaping A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| title | A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| title_full | A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| title_fullStr | A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| title_full_unstemmed | A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| title_short | A trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| title_sort | trial of pirfenidone in hospitalized adult patients with severe coronavirus disease 2019 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812696/ https://www.ncbi.nlm.nih.gov/pubmed/34855641 http://dx.doi.org/10.1097/CM9.0000000000001614 |
| work_keys_str_mv | AT zhangfengqin atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT weiyanqiu atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT heli atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT zhanghuilan atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT huqiongjie atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT yuehuihui atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT hejianhan atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT daihuaping atrialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT zhangfengqin trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT weiyanqiu trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT heli trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT zhanghuilan trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT huqiongjie trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT yuehuihui trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT hejianhan trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 AT daihuaping trialofpirfenidoneinhospitalizedadultpatientswithseverecoronavirusdisease2019 |